avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Olig2
|
ENSMUSG00000039830.8 | oligodendrocyte transcription factor 2 |
Olig3
|
ENSMUSG00000045591.5 | oligodendrocyte transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Olig2 | mm10_v2_chr16_+_91225550_91225579 | -0.37 | 2.5e-02 | Click! |
Olig3 | mm10_v2_chr10_+_19356558_19356565 | -0.29 | 9.0e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 16.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.9 | 7.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.9 | 11.2 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
1.6 | 6.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.2 | 4.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
1.1 | 5.3 | GO:0032827 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.9 | 6.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.8 | 4.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.8 | 13.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.7 | 3.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.7 | 4.3 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.7 | 2.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.7 | 2.0 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.7 | 6.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 4.0 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.7 | 3.3 | GO:1902019 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.6 | 3.8 | GO:0042997 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.6 | 1.8 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.5 | 5.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 2.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.5 | 4.4 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.5 | 6.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.5 | 1.4 | GO:0061347 | cervix development(GO:0060067) lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) planar cell polarity pathway involved in outflow tract morphogenesis(GO:0061347) planar cell polarity pathway involved in ventricular septum morphogenesis(GO:0061348) planar cell polarity pathway involved in cardiac right atrium morphogenesis(GO:0061349) planar cell polarity pathway involved in cardiac muscle tissue morphogenesis(GO:0061350) planar cell polarity pathway involved in pericardium morphogenesis(GO:0061354) regulation of cell proliferation in midbrain(GO:1904933) |
0.5 | 1.9 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.4 | 11.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 3.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 1.2 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.4 | 1.2 | GO:0060618 | nipple development(GO:0060618) |
0.4 | 1.2 | GO:0045077 | CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment(GO:0002362) peripheral T cell tolerance induction(GO:0002458) peripheral tolerance induction(GO:0002465) negative regulation of histone deacetylation(GO:0031064) negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.4 | 1.2 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
0.4 | 5.0 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.4 | 2.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.3 | 1.7 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.3 | 1.7 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.3 | 1.0 | GO:0051030 | snRNA transport(GO:0051030) |
0.3 | 3.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.3 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.3 | 2.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.3 | 1.0 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.3 | 2.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.3 | 2.3 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.3 | 1.0 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 2.4 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.3 | 0.9 | GO:0071462 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) cellular response to water stimulus(GO:0071462) |
0.3 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 4.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.3 | 1.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.3 | 2.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 0.8 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.3 | 0.8 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.2 | 3.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 0.7 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 3.0 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.2 | 2.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 3.7 | GO:0006744 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.2 | 0.6 | GO:0042697 | menopause(GO:0042697) |
0.2 | 0.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.2 | 0.9 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 2.5 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.2 | 3.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 2.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 2.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.2 | 0.5 | GO:1902071 | positive regulation of cellular response to hypoxia(GO:1900039) regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.2 | 0.9 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 4.1 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 1.2 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.1 | 0.9 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 2.0 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 1.1 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.6 | GO:2000292 | negative regulation of eating behavior(GO:1903999) regulation of defecation(GO:2000292) negative regulation of defecation(GO:2000293) |
0.1 | 3.1 | GO:0061318 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.1 | 3.5 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.1 | 8.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.1 | 1.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.9 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.1 | 5.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.1 | 0.6 | GO:0009446 | spermidine biosynthetic process(GO:0008295) putrescine biosynthetic process(GO:0009446) |
0.1 | 1.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.7 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
0.1 | 0.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.3 | GO:1904444 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of establishment of Sertoli cell barrier(GO:1904444) positive regulation of establishment of Sertoli cell barrier(GO:1904446) negative regulation of type B pancreatic cell development(GO:2000077) |
0.1 | 2.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.7 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 1.3 | GO:0046697 | decidualization(GO:0046697) |
0.1 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.1 | 1.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0000239 | pachytene(GO:0000239) |
0.1 | 4.5 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.9 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.1 | 0.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 1.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.3 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.7 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 1.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 2.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.8 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.1 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.4 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 1.5 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.1 | 0.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 2.3 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 4.7 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.2 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.1 | 0.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 1.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 2.1 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.1 | 0.8 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.1 | 0.7 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 0.1 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.8 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.0 | 3.8 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 1.3 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 4.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 11.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 1.3 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 2.4 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.0 | 1.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.9 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 2.6 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 0.2 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.0 | 0.1 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
0.0 | 1.3 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 1.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.0 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.0 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.5 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.0 | 0.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 5.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.4 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
0.0 | 0.2 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
0.0 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 1.3 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.0 | 1.6 | GO:0007632 | visual behavior(GO:0007632) |
0.0 | 0.1 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.4 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.0 | 0.5 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 2.0 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.0 | 0.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 3.2 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 1.0 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 1.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.6 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.0 | 0.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 1.1 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.2 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 1.2 | GO:0007612 | learning(GO:0007612) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 14.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 1.9 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 6.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.6 | 3.6 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 2.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.9 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.4 | 4.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 4.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 2.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.2 | 1.5 | GO:0097441 | basilar dendrite(GO:0097441) |
0.2 | 4.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 10.5 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 3.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.2 | 3.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 0.9 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.1 | 1.6 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 2.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 3.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.8 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.1 | 5.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 1.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 5.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 1.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 1.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.3 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.4 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 0.7 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 2.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.1 | 7.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.3 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 3.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 3.6 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 4.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.6 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0036396 | MIS complex(GO:0036396) |
0.0 | 0.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 1.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.7 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 1.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 9.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 1.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 0.8 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 2.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 3.1 | GO:0012506 | vesicle membrane(GO:0012506) |
0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.2 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 2.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 20.3 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.6 | 4.9 | GO:0019807 | aspartoacylase activity(GO:0019807) |
1.6 | 4.8 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
1.1 | 5.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
1.1 | 7.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.9 | 33.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.9 | 2.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
0.7 | 2.1 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.5 | 2.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.5 | 3.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.5 | 1.4 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.4 | 1.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.4 | 2.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 5.8 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 4.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 3.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 3.8 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.4 | 3.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 2.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 1.3 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.3 | 1.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.3 | 2.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 0.9 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 11.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 7.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.3 | 0.8 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.3 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 2.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 3.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 4.2 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 5.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 24.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.2 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.8 | GO:0008390 | testosterone 16-alpha-hydroxylase activity(GO:0008390) |
0.2 | 0.5 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.2 | 7.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.2 | 0.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 0.6 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.7 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.1 | 4.1 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 2.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 1.9 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 2.8 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 1.6 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 2.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 2.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 5.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 2.1 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.3 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.1 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.9 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 1.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 4.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 0.5 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 1.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 2.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.9 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 1.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.4 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) |
0.1 | 1.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 6.4 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.1 | 1.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.7 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.1 | 4.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 1.7 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 3.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 2.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 3.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.1 | 1.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 3.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.6 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 7.8 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 1.6 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 2.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 4.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 7.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.0 | 0.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 1.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 2.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 3.0 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.3 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.6 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.3 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.3 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 8.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.0 | 1.1 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 3.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 1.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.0 | 0.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 1.2 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.0 | 0.6 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 11.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 8.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 2.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 4.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 3.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.9 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.6 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 16.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.2 | 10.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 5.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 3.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 5.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 2.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 5.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 3.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 1.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.9 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 2.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 2.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 8.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 1.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 4.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 1.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.9 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.0 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 2.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 7.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 1.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 2.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.2 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 2.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.6 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 1.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.3 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 1.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |